BUTALBITAL, ASPIRIN AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Butalbital, Aspirin And Caffeine patents expire, and what generic alternatives are available?
Butalbital, Aspirin And Caffeine is a drug marketed by Lgm Pharma, Nostrum Labs Inc, Watson Labs, Actavis Elizabeth, Fosun Pharma, Halsey, Hikma Intl Pharms, Ivax Pharms, Puracap Pharm, Quantum Pharmics, and Strides Pharma. and is included in twelve NDAs.
The generic ingredient in BUTALBITAL, ASPIRIN AND CAFFEINE is aspirin; butalbital; caffeine. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.
Summary for BUTALBITAL, ASPIRIN AND CAFFEINE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 12 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 13 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUTALBITAL, ASPIRIN AND CAFFEINE at DailyMed |